Associate Professor at the University of Ferrara/Italy, born in 1958 in Bologna (I), married, one son. She graduated in medicine and surgery at the University of Bologna in 1983. She specialized in Neurology (1988) and Medical Genetics (1993) at the Universities of Bologna and Ferrara. In 2002 she achieved a PhD in Genetics at the Imperial College School of Medicine in London (UK). She is Director of both Unit (Hospital) and Section (University) of Medical Genetics. As part of her professional career she has accomplished profound research experience at the Universities of Bologna, Padova, Milan and Modena. In 1995 she moved to London where she worked as Senior Research Officer at the Hammersmith Hospital, Neuromuscular Unit, Department of Paediatrics, under the supervision of Prof. F. Muntoni. In June 1999 she returned to Italy.
She is member of the American Society of Human Genetics, the American Society of Cell and Gene Therapy, the European Society of Human Genetics, the World Muscle Society, the Italian Society of Human Genetics and the Italian Association of Myology. She is also Associate Editor of the journal Neuromuscular Disorders.
For many years already her special interest and major research effort is concentrated on dystrophinopathies and hereditary neuromuscular pathologies. Distrophinopathies are hereditary diseases caused by heterogeneous mutations in the dystrophin gene. Aim of the actually conducted research is to identify the processes which determine the regulation of expression of this specific gene, particularly referring to the process of splicing and its modulation. Her research team is studying in vitro and in vivo systems to modulate mutations of the gene with antisense oligonucleotides while using new systems of release (nanomaterials). Furthermore the team is in charge with the definition of the RNA profile of various hereditary pathologies and the identification of molecular markers both in humans and in animal models. She is also member of several European research groups that in particular are studying new therapeutic approaches of dystrophinopathies and other neuromuscular pathologies as well as innovative aspects of molecular diagnostics with focus on high throughput techniques and next generation sequencing. She is provided with all ethical aspects referring to medical genetics and the therapy of genetic diseases. She is member of the Project Ethical Committee of the TREAT-NMD NoE, of group of genetic quality control at the Institute of Health (Italy), and of the key group of Medical Genetic Coordination of the Regione Emilia-Romagna (Italy).